TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Danamedicus AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
560
|
1,595
|
1,548 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-247
|
647
|
542 |
| EBITDA |
-293
|
613
|
530 |
| Total assets |
1,384
|
2,154
|
2,021 |
| Current assets |
1,384
|
2,154
|
2,021 |
| Current liabilities |
19
|
132
|
109 |
| Equity capital |
1,344
|
1,938
|
1,828 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
97.1%
|
90.0%
|
90.5% |
| Turnover per employee |
280
|
798
|
774 |
| Profit as a percentage of turnover |
-44.1%
|
40.6%
|
35.0% |
| Return on assets (ROA) |
-17.8%
|
30.0%
|
26.8% |
| Current ratio |
7284.2%
|
1631.8%
|
1854.1% |
| Return on equity (ROE) |
-18.4%
|
33.4%
|
29.6% |
| Change turnover |
-1,035
|
47
|
241 |
| Change turnover % |
-65%
|
3%
|
18% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.